35597-85-4Relevant academic research and scientific papers
1, 2, 4-triazoles clubbed pyrimidine compounds with synthesis, antimicrobial, antituberculosis, antimalarial, and anti-protozoal studies
Chan-Bacab, Manuel J.,Parmar, Rahul B.,Patel, Navin B.,Rivera, Gildardo,Soni, Hetal I.
, p. 617 - 624 (2021/09/30)
Triazoles are famous as an antifungal agent. Itraconazole and fluconazole are the best examples of antifungal drugs available in the market, which consist of an active triazole moiety. Pyrimidines are also bioactive molecules which shows multiple bioactivity. It’s an effort to synthesize pyrimidine clubbed triazole to enhance bioactivity. To synthesize new active pyrimidine clubbed triazole biomolecule and to evaluate these new products for better drug potential as antimicrobial, antituberculosis, antimalarial, and anti-protozoal, N-[4-(substituted phenyl)-6-(substituted aryl) pyrimidine-2-yl]-2-[(4H-1,2,4-triazol-4-yl)amino]acetamide(3A-J) were synthesized by different method such as cyclization, condensation, purification and crystallization. The newly synthesized compounds were characterized by IR,1H NMR,13C NMR and mass spectral analysis and screened for antibacterial, antifungal, anti-tuberculosis, antimalarial, and antiprotozoal activities. These compounds satisfied the bioactive response and simple way for the synthesis.
Design, synthesis, molecular modeling, and ADMET studies of some pyrazoline derivatives as shikimate kinase inhibitors
James, Jainey P.,Ishwar Bhat,More, Uttam A.,Joshi, Shrinivas D.
, p. 546 - 559 (2017/11/16)
A series of pyrazoline derivatives were synthesized and their structures have been characterized by IR, 1H NMR, 13C NMR, mass spectral and elemental analysis. The novel compounds were designed as Mycobacterium tuberculosis shikimate
2-Substituted 1-Azabicycloalkanes, a New Class of Non-Opiate Antinociceptive Agents
Carson, John R.,Carmosin, Richard J.,Vaught, Jeffry L.,Gardocki, Joseph F.,Costanzo, Michael J.,et al.
, p. 2855 - 2863 (2007/10/02)
2-Substituted 1-azabicycloalkanes (3- and 5-aryloctahydroindolizines 2 and 11, 3-cyclohexyloctahydroindolizine 12, 4-aryloctahydroquinolizines 13, and 3-arylhexahydropyrrolizines 14) constitute a new class of non-opiate antinociceptive agents.These compou
